Last reviewed · How we verify

NCT05370833

Transcranial Direct Current Stimulation in Clinical Setting to Reduce Pain in Older Workers

Status unknown NA Last updated 12 July 2023
What this trial tests

NA trial testing transcranial direct current stimulation in Chronic Pain in 24 participants. Status unknown.

Timeline
15 May 2022
Primary endpoint
30 April 2024
30 May 2024

Quick facts

Lead sponsorUniversité de Sherbrooke
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment24
Start date15 May 2022
Primary completion30 April 2024
Estimated completion30 May 2024
Sites2 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Université de Sherbrooke — full company profile →

Who can join

56 and older, any sex, with Chronic Pain or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic pain is one of the main factors influencing workers' retention at work. Considering that the prevalence of suffering from chronic pain increases with age, older workers are most likely to be absent from work because of their pain. Transcranial direct current stimulation (tDCS) is a treatment option to reduce chronic pain. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Université de Sherbrooke trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05370833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing